TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Opthea Ltd (OPT)

Healthcare Biotechnology
3.40 $
+7.2% vs. previous close
Closing price · As of: 2. Jul 2026

Opthea Ltd (OPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 25), "Revenue" came in at 0.0 million $. Tick rows to compare them in a chart.

Income Statement OPT
Tick rows to compare them in a chart (up to 4) Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q1 25
-0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0
0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0
-0.3 0.1 -0.1 -0.1 0.1 0.0 0.1 0.0 0.0 -0.1 0.0
8.1 43 31 68 48 92 45 90 130 139 69 1.8
6.4 3.6 8.4 18 11 25 9.8 20 13 9.8 1.8
15 54 39 85 60 118 46 106 144 287 85 4.4
-14 -54 -38 -83 -62 -118 -53 -106 -144 -288 -85 -4.1
0.1 5.2 15 16 30 22 0.0
-15 -56 -39 -85 -62 -118 -52 -103 -155 -193 -137 -3.7
1.6 -4.0 2.3 4.9 1.6 -3.1 2.9 -5.7 -7.7 -6.6 -6.0 -1.2
-13 -52 -37 -80 -60 -115 -49 -97 -147 -186 -131 -2.5
-14 -54 -38 -83 -62 -113 -53 -106 -139 -147 -115 -4.5

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?